{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:07:47Z","timestamp":1759018067583,"version":"3.44.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,7,1]],"date-time":"2000-07-01T00:00:00Z","timestamp":962409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2000,7]]},"DOI":"10.1053\/jinf.2000.0678","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T09:56:27Z","timestamp":1032429387000},"page":"50-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Adherence, Side Effects and Efficacy of Stavudine plus Lamivudine plus Nelfinavir in Treatment-experienced HIV-infected Patients"],"prefix":"10.1016","volume":"41","author":[{"given":"B","family":"Roca","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.J","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Arnedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/jinf.2000.0678_RF1","first-page":"43","volume":"47(RR-5)","year":"1998","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1053\/jinf.2000.0678_RF2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1053\/jinf.2000.0678_RF3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.1997.03550010077044","article-title":"Protease inhibitors in the homeless","volume":"278","author":"Bangsberg","year":"1997","journal-title":"JAMA"},{"key":"10.1053\/jinf.2000.0678_RF4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jama.280.6.567","article-title":"Adherence and antiretroviral therapy in injection drug users","volume":"280","author":"Sherer","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/jinf.2000.0678_RF5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.7326\/0003-4819-129-7-199810010-00012","article-title":"Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease","volume":"129","author":"Lerner","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2000.0678_RF6","first-page":"S271","article-title":"Adherence: a necessity for successful HIV combination therapy","volume":"113","author":"Chesney","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0678_RF7","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00002030-199714000-00002","article-title":"Potential factors affecting adherence with HIV therapy","volume":"11","author":"Mehta","year":"1997","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0678_RF8","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-129-6-199809150-00015","article-title":"The era of adherence to HIV therapy","volume":"129","author":"Altice","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2000.0678_RF9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7326\/0003-4819-131-2-199907200-00002","article-title":"Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions","volume":"131","author":"Lucas","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/jinf.2000.0678_RF10","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2165\/00003495-199651050-00009","article-title":"Stavudine: a review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection","volume":"51","author":"Lea","year":"1996","journal-title":"Drugs"},{"key":"10.1053\/jinf.2000.0678_RF11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00003495-199753040-00008","article-title":"A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in the management of HIV infection","volume":"53","author":"Perry","year":"1997","journal-title":"Drugs"},{"key":"10.1053\/jinf.2000.0678_RF12","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1345\/aph.18089","article-title":"Nelfinavir mesylate: a protease inhibitor","volume":"33","author":"Pai","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1053\/jinf.2000.0678_RF13","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jama.280.1.78","article-title":"Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society \u2013 USA Panel","volume":"280","author":"Carpenter","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/jinf.2000.0678_RF14","first-page":"1","volume":"41 (HR-17)","year":"1992","journal-title":"MMWR"},{"key":"10.1053\/jinf.2000.0678_RF15","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1176\/ps.49.8.1021","article-title":"Adherence to complex combination antiretroviral therapies by HIV-positive drug abusers","volume":"49","author":"Malow","year":"1998","journal-title":"Psychiatr Serv"},{"key":"10.1053\/jinf.2000.0678_RF16","first-page":"10","article-title":"Update on adherence to HIV therapy","author":"Eldred","year":"1998","journal-title":"The Hopkins HIV Report"},{"key":"10.1053\/jinf.2000.0678_RF17","doi-asserted-by":"crossref","first-page":"F131","DOI":"10.1097\/00002030-199811000-00005","article-title":"Predictors of long term response to protease inhibitor therapy in a cohort of HIV-infected patients","volume":"12","author":"Casado","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0678_RF18","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/315171","article-title":"Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response","volume":"181","author":"Connick","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1053\/jinf.2000.0678_RF19","first-page":"6","article-title":"Adherence in the era of protease inhibitors","author":"Eldred","year":"1997","journal-title":"The Hopkins HIV Report"},{"key":"10.1053\/jinf.2000.0678_RF20","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.279.24.1977","article-title":"Public health implications of antiretroviral therapy and HIV drug resistance","volume":"279","author":"Wainberg","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/jinf.2000.0678_RF21","first-page":"57","article-title":"Measuring HIV treatment adherence in clinical practice","volume":"10","author":"Hecht","year":"1998","journal-title":"AIDS Clinical Care"},{"key":"10.1053\/jinf.2000.0678_RF22","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/00002030-199906180-00014","article-title":"The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group","volume":"13","author":"Haubrich","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0678_RF23","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jama.280.6.544","article-title":"Self-reported antiretroviral therapy in injection drug users","volume":"280","author":"Celentano","year":"1998","journal-title":"JAMA"},{"key":"10.1053\/jinf.2000.0678_RF24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0163-4453(99)90006-3","article-title":"Stavudine, lamivudine and indinavir in drug users and non-drug users HIV-infected patients: adherence, side effects and efficacy","volume":"39","author":"Roca","year":"1999","journal-title":"J Infect"},{"key":"10.1053\/jinf.2000.0678_RF25","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1097\/00002030-199909100-00021","article-title":"Sociodemographic and psychological variables influencing adherence to antiretroviral therapy","volume":"13","author":"Gordillo","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0678_RF26","unstructured":"Paterson, D, Swindells, S, Mohr, J, et al., How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMSCaps. Sixth Conference on Retroviruses and Opportunistic Infections, 1999"},{"key":"10.1053\/jinf.2000.0678_RF27","article-title":"Adherence and effectiveness of highly active antiretroviral therapy","volume":"158","author":"Knobel","year":"1953","journal-title":"Arch Intern Med 1998"},{"key":"10.1053\/jinf.2000.0678_RF28","first-page":"1112","article-title":"Virological failure and adherence to antiretroviral therapy in HIV-infected patients","volume":"12","author":"Rodri\u0131\u0301guez-Rosado","year":"1998","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0678_RF29","first-page":"78","article-title":"Adherencia al tratamiento antirretroviral de gran actividad: impacto de una intervenci\u00f3n de asesoramiento individualizado","volume":"17","author":"Knobel","year":"1999","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1053\/jinf.2000.0678_RF30","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1525-1497.1999.00334.x","article-title":"Adherence to combination antiretroviral therapies in HIV patients of low health literacy","volume":"14","author":"Kalichman","year":"1999","journal-title":"J Gen Intern Med"},{"key":"10.1053\/jinf.2000.0678_RF31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/apc.1999.13.185","article-title":"Predictors of self-reported adherence in persons living with HIV disease","volume":"13","author":"Holzemer","year":"1999","journal-title":"Aids Patient Care STDS"},{"key":"10.1053\/jinf.2000.0678_RF32","first-page":"S41","article-title":"Nelfinavir, a new protease inhibitor: early clinical results","volume":"13","author":"Powderly","year":"1999","journal-title":"AIDS"},{"key":"10.1053\/jinf.2000.0678_RF33","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1258\/0956462981921189","article-title":"Disorders of fat distribution in HIV infection","volume":"9","author":"Shaw","year":"1998","journal-title":"Int J STD AIDS"},{"key":"10.1053\/jinf.2000.0678_RF34","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1053\/jinf.2000.0678_RF35","first-page":"383","article-title":"Adverse metabolic disorders during highly active antiretroviral treatments (HAART) of HIV disease","volume":"25","author":"Vigouroux","year":"1999","journal-title":"Diabetes Metab"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445300906789?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445300906789?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:24:08Z","timestamp":1758986648000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445300906789"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,7]]}},"alternative-id":["S0163445300906789"],"URL":"https:\/\/doi.org\/10.1053\/jinf.2000.0678","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2000,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adherence, Side Effects and Efficacy of Stavudine plus Lamivudine plus Nelfinavir in Treatment-experienced HIV-infected Patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/jinf.2000.0678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}